60 likes | 76 Views
Rising prevalence of diabetes in Europe is the key factor that will drive Europe self-monitoring blood glucose devices market during the forecast period.
E N D
Europe Self-Monitoring Blood Glucose Devices Market to exceed $6.5 bn by 2024: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com
Key Insights from Europe Self-Monitoring Blood Glucose Devices Market • Increasing number of baby boomers and rising number of people diabetic cases will act as primary driver for growth of Europe self-monitoring blood glucose devices market over the forecast timeframe. • Growth of home healthcare sector and technological advancements in homecare SMBG devices has stimulated adoption rate. Moreover, growing demand for minimal invasive disease monitoring tools coupled with rising number of health-conscious people will stimulate growth of home healthcare self-monitoring blood glucose devices market. • Presence of associations such as Primary Care Diabetes Society creating awareness about the target disease to promote adoption of diabetes monitoring tools will positively impact industry growth over the coming years. • Continuous glucose monitors (CGM) product segment is anticipated to witness robust growth of 5.6% during the forecast period. These devices form an essential part of homecare diabetes monitoring as it delivers real time blood glucose readings as well as detects abnormal patterns of glycemia many folds better than conventional systems will drive business growth of CGM devices. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com
Continued... • Diagnostic centers and clinics end-user segment of Europe self-monitoring blood glucose devices market is forecasted to witness considerable growth owing to rising number of people suffering from abnormal blood glucose levels and growing awareness about diabetes and diabetic treatment. Increasing per capita healthcare expenditure will positively impact growth of diagnostic centers and clinics segment. • UK self-monitoring blood glucose devices market will witness 4.3% CAGR during the forecast period owing to technological advancements in SMBG devices and high technological adoption in the country. Growing demand for self-diabetes monitoring devices applicable to homecare setting as well as growing geriatric population base will fuel industry growth over the coming years. • Few notable industry players operating in Europe self-monitoring blood glucose devices market are Abbott Laboratories, All Medicus, Arkray, B. Braun Melsungen AG, Bayer Healthcare, Bionime Corporation, Dexcom, F. Hoffmann-La Roche, Johnson & Johnson, LifeScan, Medtronic, Nipro Diagnostics, Nova Biomedical, Sinocare and Trividia Health. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com
Europe Self-Monitoring Blood Glucose Devices Market ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com
Browse Full Market Research Report On Europe Self-Monitoring Blood Glucose Devices Market @ https://bit.ly/2RhrOPZ Request for a Sample of this Research Report @ https://bit.ly/2ByRqlC ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com
Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com